Drug intelligence / Profile preview

gallium 68 macroaggregated albumin

Development stage
Phase 3
Modality
Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics
Administration
Intravenous
01

Overview

Gallium 68 macroaggregated albumin (68Ga-MAA) is a radiopharmaceutical used for diagnostic imaging, particularly for lung perfusion studies using Positron Emission Tomography (PET). It consists of macroaggregated human serum albumin particles labeled with the positron-emitting radioisotope gallium-68. The particles become trapped in the first capillary bed encountered after intravenous injection, creating a temporary blockade of terminal arterioles/capillaries in the lung, allowing for visualization of pulmonary blood flow. 68Ga-MAA can be prepared from commercially available kits originally designed for technetium-99m labeling of MAA. The labeling process typically involves heating at optimal temperatures (around 90°C) to achieve high radiochemical purity. 68Ga-MAA has also been investigated for use in Selective Internal Radiation Therapy (SIRT) dosimetry and treatment planning.

Other names
68Ga-MAAgallium 68 macro-aggregated albumingallium68 macro-aggregated albumingallium-68 macro-aggregated albumin[68Ga]Ga-MAA

Beyond the preview

Go deeper on gallium 68 macroaggregated albumin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on gallium 68 macroaggregated albumin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call